.png){kind=icon}
返回
Target repurposing for neglected diseases
.png){kind=icon}
OA
AI
DOI：10.4155/FMC.11.92.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Infectious diseases are an enormous burden to global health and, since drug discovery is costly, those infectious diseases that affect the developing world are often not pursued by commercial drug-discovery efforts. Therefore, pragmatic means by which new therapeutics can be discovered are needed. One such approach is target repurposing, where pathogen targets are matched with homologous human targets that have been pursued for drug discovery for other indications. In many cases, the medicinal chemistry, structural biology and biochemistry knowledge around these human targets can be directly repurposed to launch and accelerate new drug-discovery efforts against the pathogen targets. This article describes the overarching strategy of target repurposing as a tool for initiating and prosecuting neglected disease drug-discovery programs, highlighting this approach with three case studies.
Keyword:
IMMUNODEFICIENCY-VIRUS PROTEASE
TRYPANOSOMA-BRUCEI
N-MYRISTOYLTRANSFERASE
ORNITHINE-DECARBOXYLASE
MALARIA PARASITES
DRUG DEVELOPMENT
ESSENTIAL ENZYME
HIV-1 PROTEASE
INHIBITOR
DESIGN
期刊
IF:
3.4
论文数:
3.0K
被引数:
6.2K
机构
引用论文
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin.png)
Cancers
OAAI
CancersIF0
OAAI分享收藏分享收藏
查看更多内容